Feb. 14, 2025
WASHINGTON, D.C. – Otolith Labs, a medical technology company developing prescription medical devices for vestibular disorders, has announced findings from an exploratory user study evaluating the impact of vestibular stimulation technology on cybersickness during virtual reality (VR) experiences. The study results indicate that subjects using Otolith technology reported lower nausea levels and longer VR engagement durations compared to those without